Results 171 to 180 of about 108,435 (311)

Decoding the Pathophysiology of Autoimmune Diseases—Mechanism, Triggers, and Nanotherapeutics: A Review

open access: yesAdvanced NanoBiomed Research, EarlyView.
This review highlights how autoimmune diseases arise from intertwined immunological, genetic, and environmental factors, emphasizing gut microbiota dysbiosis as a pivotal driver. It outlines emerging nanotechnology‐based strategies—such as liposomes, hydrogels, and polymeric nanoparticles—that enhance targeted drug delivery, minimize systemic toxicity,
Md. Meraj Ansari   +5 more
wiley   +1 more source

Effectiveness of antenatal intravenous immunoglobulin treatment in recurrent fetal and neonatal alloimmune thrombocytopenia. [PDF]

open access: yesUltrasound Obstet Gynecol
Zloto K   +7 more
europepmc   +1 more source

Hemolysis related to intravenous immunoglobulins is dependent on the presence of anti‐blood group A and B antibodies and individual susceptibility [PDF]

open access: hybrid, 2017
Orell Mielke   +9 more
openalex   +1 more source

IL-1B Polymorphism in Association With Initial Intravenous Immunoglobulin Treatment Failure in Taiwanese Children With Kawasaki Disease

open access: bronze, 2010
Ken‐Pen Weng   +9 more
openalex   +2 more sources

PRACTICAL ASPECTS OF THE APPLICATION OF INTRAVENOUS IMMUNOGLOBULINS FOR INTRAVENOUS ADMINISTRATION IN VARIOUS PATHOLOGIES

open access: hybrid, 2021
S.S. Vakhlayrskaya   +5 more
openalex   +1 more source

Association of Abatacept With Lower Mortality Risk Compared to Rituximab in Rheumatoid Arthritis–Associated Interstitial Lung Disease: An Emulated Target Trial

open access: yesArthritis &Rheumatology, EarlyView.
Objective The optimal treatment strategy for rheumatoid arthritis–associated interstitial lung disease (RA‐ILD) remains uncertain, and direct comparative data between biologics are limited. This study aimed to evaluate the effectiveness and safety of abatacept compared with rituximab in patients with RA‐ILD.
Po‐Cheng Shih   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy